Evidence map›Paper›PMID 36554688›Full record

ArticleInternational journal of environmental research and public health2022

Knowledge, Attitude, and Acceptance of Sinopharm and AstraZeneca's COVID-19 Vaccines among Egyptian Population: A Cross-Sectional Study.

Marian S Boshra, Marwa O Elgendy, Lamiaa N Abdelaty, Mahmoud Tammam, Abdullah S Alanazi, Abdulaziz Ibrahim Alzarea, Saud Alsahali, Rania M Sarhan

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marian S BoshraClinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62511, Egypt.ORCID 0000-0003-4916-4359
Marwa O ElgendyClinical Pharmacy Department, Beni-Suef University Hospitals, Faculty of Medicine, Beni-Suef University, Beni-Suef 62511, Egypt.ORCID 0000-0002-5466-0552
Lamiaa N AbdelatyDepartment of Clinical Pharmacy, Faculty of Pharmacy, October 6 University, Giza 12525, Egypt.
Mahmoud TammamIQVIA, Cairo 10245, Egypt.
Abdullah S AlanaziDepartment of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka 72388, Saudi Arabia.ORCID 0000-0002-8120-4018
Abdulaziz Ibrahim AlzareaClinical Pharmacy Department, College of Pharmacy, Jouf University, Sakaka 72388, Saudi Arabia.ORCID 0000-0003-0604-6299
Saud AlsahaliDepartment of Pharmacy Practice, Unaizah College of Pharmacy, Qassim University, Unaizah 51911, Saudi Arabia.
Rania M SarhanClinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62511, Egypt.ORCID 0000-0002-0781-6454

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to evaluate the Egyptian population's preference and awareness related to available COVID-19 vaccines and to determine different factors that can affect beliefs concerning these vaccines.

methodsA cross-sectional web-based study was carried out among the general population in Egypt. Data collection was conducted via an online questionnaire.

resultsAbout 426 subjects participated in the survey. Vaccine preference is nearly equally even (50%) among all respondents. There was no significant difference in vaccine preference according to age, gender, residence, educational level, or social status. About 50% of public respondents mentioned that both AstraZeneca and Sinopharm vaccines do not offer protection against new variant COVID-19 strains. Healthcare workers are the lowest respondents to agree that vaccines offer protection against new COVID-19 variants (10.9%) compared to unemployed respondents (20.3%) and other professions (68.8%) with a statistically significant difference (

conclusionsMost of the study population has satisfying knowledge about the COVID-19 vaccine. Continuous awareness campaigns must be carried out so that the people's background is updated with any new information that would help in raising the trust in vaccination.

Indexed as

COVID-19VaccinesChildCOVID-19 VaccinesCross-Sectional StudiesEgyptHealth Knowledge, Attitudes, PracticeHumansSARS-CoV-2VaccinationCOVID-19 VaccinesVaccinesAstraZenecaawarenessCOVID-19Sinopharmvaccines

Identifiers

PMID36554688
PMCPMC9778847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.